Company: RPTX
Filing Date: 2025-11-17
Form Type: DEFA14A
Source: 0001193125-25-284040
Chunk: 39

Company: Repare Therapeutics Inc.
Filing Date: 2025-11-17
Form: DEFA14A
Chunk 39
---
 by Law or the Interim Order, or with the Purchaser’s written consent; |

| (g) | not without the prior written consent of the Purchaser, waive the deadline for the submission of proxies by 
 Shareholders for the Meeting;                                                                               |

| (h) | promptly advise the Purchaser of any substantive written communication received from, or claims brought by (or,                                                                                                                                        
 to the knowledge of the Company, threatened to be brought by), any person in opposition to the Arrangement and/or any purported exercise or withdrawal of Dissent Rights by Shareholders and, subject to Law, cooperate and provide the Purchaser with 
 (i) an opportunity to review and comment upon in advance any written communications to be sent by or on behalf of the Company to any such person and (ii) a copy of any such written communication;                                                    |

| (i) | not settle, compromise or make any payment with respect to, or agree to settle, compromise or make any payment            
 with respect to, any exercise or purported exercise of Dissent Rights without the prior written consent of the Purchaser; |

| (j) | not waive any failure by any holder of Common Shares to timely deliver a notice of exercise of Dissent Rights,                                                                             
 make any payment or settlement offer, or agree to any payment or settlement prior to the Effective Time with respect to Dissent Rights without the prior written consent of the Purchaser; |

| (k) | at the request of the Purchaser from time to time, provide the Purchaser with a list of (i) the registered                                                                                                                                          
 Shareholders, together with their addresses and respective holdings of Common Shares, (ii) the names, addresses and holdings of all persons having rights issued by the Company to acquire Common Shares (including holders of Incentive Securities 
 and ESPP Shares, as applicable), and (iii) participants and book-based nominee registrants such as Broadridge Financial Solutions, Inc., CDS & Co., and CEDE & Co., and non-objecting                                                               
 beneficial owners of Common Shares, together with their addresses and respective holdings of Common Shares, all as can be reasonably obtained by the Company using the procedures set forth under Securities Laws. The Company shall from time      |

- 20 -

| to time require that its registrar and transfer agent furnish the Purchaser with such additional information, including updated or additional lists of Shareholders, and lists of securities                                                       
 positions and other assistance as the Purchaser may reasonably request in order to be able to communicate with respect to the